The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated•Originally published 22 April 2026•Updated 23 April 2026•

1 min read

BOSS Zhipin Continues Share Buybacks with RMB 985 Million Deployed Year-to-Date

FDA and Novo Nordisk logos above a laboratory scene with computer monitors, chemical structures, medicine bottles, and pills.

Key Facts

1KANZHUN LIMITED, known as BOSS Zhipin, utilized over RMB27.2 million to repurchase 579,118 ordinary shares on April 21.

2The total amount deployed toward share repurchases year-to-date in 2026 has reached nearly RMB958 million.

KANZHUN LIMITED, operating as BOSS Zhipin, has announced a further execution of its ongoing share repurchase program. On April 22, the company repurchased an additional 580,426 ordinary shares, utilizing over RMB 27.2 million. This latest transaction brings the total amount deployed toward share repurchases in 2026 to over RMB 985 million year-to-date. These consistent buybacks underscore management's commitment to delivering shareholder returns and their confidence in the company's long-term intrinsic value. Such programs are typically viewed as bullish signals by the market, as they support stock price stability and reduce share dilution. The Chinese recruitment leader continues to demonstrate proactive capital management despite broader economic conditions.

about 1 month ago

Version History

Version 1about 1 month ago

What changed: The story was updated to include an additional share repurchase executed on April 22, increasing the total year-to-date expenditure from RMB 958 million to over RMB 985 million.